亚太地区生物安全柜市场预测至 2028 年 - COVID-19 影响和区域分析 - 按处理的产品(生物产品和有毒产品)、类别(工作托盘、侧板结构和配件)、类型(I 类生物安全柜、II 类) A2类&II类B1类、II类B2类生物安全柜、II类生物安全柜、定制柜等)、应用(医疗卫生、疾病预防、食品安全、生物制药、环境监测等)、结束用户(学术中心、生物技术和制药公司、微生物中心、研发中心、医院和诊所、诊断实验室等)

Historic Data: 2021-2022   |   Base Year: 2023   |   Forecast Period: 2024-2028


No. of Pages: 145    |    Report Code: BMIRE00028595    |    Category: Life Sciences

Asia Pacific Biosafety Cabinet Market

亚太地区生物安全柜市场预计将从2023年的3623万美元增长到2028年的5742万美元。预计2023年至2028年复合年增长率为9.6% . 

越来越多地采用细胞疗法和再生疗法正在推动亚太地区生物安全柜市场

再生医学可以替代或治愈因年龄、疾病或创伤而受损的组织和器官,并有助于治疗先天性残疾。在过去的四分之一个世纪里,组织工程行业出现了,现在已经发展成为更广泛的再生医学领域。再生医学是一个快速发展的跨学科领域,涉及工程科学来开发旨在维持、修复、替代和增强生物功能的临床疗法。细胞系发育是再生医学至关重要且不变的部分,有助于了解如何治疗从骨折到神经退行性疾病等损伤和疾病。这些开发程序和协议主要涉及使用 I 类和 II 类生物安全柜以获得最佳结果并避免纯细胞培养物的污染。这也有助于遵守细胞产品良好生产规范的原则。基于细胞的疗法广泛用于治疗各种疾病,例如癌症和自身免疫性疾病。因此,基于细胞的治疗产品的产量有所增加。因此,在预测期内,再生药物和细胞疗法的采用增加预计将成为亚太地区生物安全柜市场的普遍趋势。

亚太地区生物安全柜市场概览

亚太地区生物安全柜市场分为中国、日本、澳大利亚、印度、韩国和其他地区亚太地区。 2023年,中国占据市场主导地位。由于生物技术公司的不断增加、研发设施的不断完善以及生物制药公司投资的增加,中国的生物安全柜市场经历了巨大的增长。制药和生物技术公司不断增加的战略举措(例如合作伙伴关系以及对研发活动的日益关注)加速了该国的市场增长。随着国家药品监督管理局(NPMA)法规的修改,中国的生物技术产业近来加速发展;许多投资者正在热切地为这些公司提供资金。公司的发展推动了中国生物安全柜市场的增长。 2022年11月,海尔生物医学举行首批新型生物安全柜(型号HR700-IIA2和HR900-IIA-D)上市仪式,向国际客户交付。据估计,在预测期内,产品的推出将为亚太地区生物安全柜市场提供机会。

亚太地区生物安全柜市场收入和预测至 2028 年(百万美元) )

亚太地区生物安全柜市场细分< /strong>

亚太地区生物安全柜市场按所处理的产品、类别、类型、应用、最终用户和国家/地区进行细分。

根据所处理的产品,亚太地区生物安全柜市场分为生物制品和有毒产品。 2023年,生物制品细分市场在亚太生物安全柜市场中占据较大份额。    

按类别划分,亚太地区生物安全柜市场为分为工作托盘、侧板结构和配件。 2023年,工作托盘细分市场在亚太生物安全柜市场中占据最大份额。

根据类型,亚太生物安全柜市场分为I类生物安全柜、 II 类 A2 型二级B1型、二级B2型生物安全柜、二级生物安全柜、定制柜等。 II 类 A2 型和2023年,II类B1类细分市场在亚太生物安全柜市场中占据最大份额。

根据应用,亚太生物安全柜市场细分为医疗健康、疾病预防、食品安全、生物制药、环境监测等。 2023年,疾病预防领域在亚太地区生物安全柜市场中占据最大份额。

根据最终用户,亚太地区生物安全柜市场分为学术领域中心、生物技术和制药公司、微生物中心、研究与机构开发中心、医院和诊所、诊断实验室等。生物技术与2023年,制药公司细分市场在亚太地区生物安全柜市场中占据最大份额。

按国家划分,亚太地区生物安全柜市场分为中国、印度、日本、韩国、澳大利亚和亚太其他地区。我们的区域分析表明,2023 年中国将主导亚太地区生物安全柜市场。

ACMAS Technologies、Biobase Biodusty Co Ltd、Esco Group of Companies、海尔生物医疗、Heal Force Bio- Meditech Holdings Ltd,国际科学设备营销商Technologies (IMSET)、Kewaunee Scientific Corp、Labconco Corp、NuAire Inc 和 Thermo Fisher Scientific Inc 是亚太生物安全柜市场的领先公司。        



Asia Pacific Biosafety Cabinet Strategic Insights

Strategic insights for Asia Pacific Biosafety Cabinet involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.

strategic-framework/asia-pacific-biosafety-cabinet-market-strategic-framework.webp
Get more information on this report

Asia Pacific Biosafety Cabinet Report Scope

Report Attribute Details
Market size in 2023 US$ 36.23 Million
Market Size by 2028 US$ 57.42 Million
Global CAGR (2023 - 2028) 9.6%
Historical Data 2021-2022
Forecast period 2024-2028
Segments Covered By 经营产品
  • 生物制品和有毒产品
By 类别
  • 工作托盘
  • 侧面板结构
  • 配件
By 类型
  • I 级生物安全柜
  • II 级 A2 型和 II 级 B1 型
  • II 级 B2 型生物安全柜
  • II 级生物安全柜
  • 定制柜
By 应用领域
  • 医疗卫生
  • 疾病预防
  • 食品安全
  • 生物制药
  • 环境监测
Regions and Countries Covered 亚太地区
  • 中国
  • 印度
  • 日本
  • 澳大利亚
  • 亚太其他地区
Market leaders and key company profiles
  • ACMAS Technologies
  • Biobase Biodusty Co Ltd
  • Esco Group of Companies
  • Haier Biomedical
  • Heal Force Bio-Meditech Holdings Ltd
  • International Marketers for Scientific Equipment’s & Technologies (IMSET)
  • Kewaunee Scientific Corp
  • Labconco Corp
  • NuAire Inc
  • Thermo Fisher Scientific Inc
  • Get more information on this report

    Asia Pacific Biosafety Cabinet Regional Insights

    The regional scope of Asia Pacific Biosafety Cabinet refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.

    geography/asia-pacific-biosafety-cabinet-market-geography.webp
    Get more information on this report

    The List of Companies - Asia Pacific Biosafety Cabinet Market

    1. ACMAS Technologies
    2. Biobase Biodusty Co Ltd
    3. Esco Group of Companies
    4. Haier Biomedical
    5. Heal Force Bio-Meditech Holdings Ltd
    6. International Marketers for Scientific Equipment’s & Technologies (IMSET)
    7. Kewaunee Scientific Corp
    8. Labconco Corp  
    9. NuAire Inc 
    10. Thermo Fisher Scientific Inc
    Frequently Asked Questions
    How big is the Asia Pacific Biosafety Cabinet Market?

    The Asia Pacific Biosafety Cabinet Market is valued at US$ 36.23 Million in 2023, it is projected to reach US$ 57.42 Million by 2028.

    What is the CAGR for Asia Pacific Biosafety Cabinet Market by (2023 - 2028)?

    As per our report Asia Pacific Biosafety Cabinet Market, the market size is valued at US$ 36.23 Million in 2023, projecting it to reach US$ 57.42 Million by 2028. This translates to a CAGR of approximately 9.6% during the forecast period.

    What segments are covered in this report?

    The Asia Pacific Biosafety Cabinet Market report typically cover these key segments-

  • 经营产品 (生物制品和有毒产品)
  • 类别 (工作托盘, 侧面板结构, 配件)
  • 类型 (I 级生物安全柜, II 级 A2 型和 II 级 B1 型, II 级 B2 型生物安全柜, II 级生物安全柜, 定制柜)
  • What is the historic period, base year, and forecast period taken for Asia Pacific Biosafety Cabinet Market?

    The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Asia Pacific Biosafety Cabinet Market report:

  • Historic Period : 2021-2022
  • Base Year : 2023
  • Forecast Period : 2024-2028
  • Who are the major players in Asia Pacific Biosafety Cabinet Market?

    The Asia Pacific Biosafety Cabinet Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:

  • ACMAS Technologies
  • Biobase Biodusty Co Ltd
  • Esco Group of Companies
  • Haier Biomedical
  • Heal Force Bio-Meditech Holdings Ltd
  • International Marketers for Scientific Equipment’s & Technologies (IMSET)
  • Kewaunee Scientific Corp
  • Labconco Corp
  • NuAire Inc
  • Thermo Fisher Scientific Inc
  • Who should buy this report?

    The Asia Pacific Biosafety Cabinet Market report is valuable for diverse stakeholders, including:

    • Investors: Provides insights for investment decisions pertaining to market growth, companies, or industry insights. Helps assess market attractiveness and potential returns.
    • Industry Players: Offers competitive intelligence, market sizing, and trend analysis to inform strategic planning, product development, and sales strategies.
    • Suppliers and Manufacturers: Helps understand market demand for components, materials, and services related to concerned industry.
    • Researchers and Consultants: Provides data and analysis for academic research, consulting projects, and market studies.
    • Financial Institutions: Helps assess risks and opportunities associated with financing or investing in the concerned market.

    Essentially, anyone involved in or considering involvement in the Asia Pacific Biosafety Cabinet Market value chain can benefit from the information contained in a comprehensive market report.